Invitation to the presentation of Elekta’s second quarter 2022/23
STOCKHOLM – Elekta (EKTA-B.ST) invites analysts and investors to a presentation of the second quarter 2022/23 at 10:00 a.m. CET on November 24. The interim report for the second quarter will be published at 7:30 a.m. CET on the same day.
The company’s development will be presented by Elekta’s President and CEO Gustaf Salford together with CFO Tobias Hägglöv. After the presentation, held in English, a Q&A session will follow.
The presentation will be broadcasted live on the web. It will be necessary to join the phone conference if you plan to ask questions. A recording of the webcast can be found on Elekta’s website after the call.
Time: Thursday, November 24, at 10:00 a.m. CET
Telephone numbers to join phone conference:
UK: +44 207 107 0613
USA: +1 631 570 5613
Sweden: +46 8 5051 0031
# # #
For further information, please contact:
Cecilia Ketels, Head of Investor Relations
Tel: +46 76 611 7625, e-mail: email@example.com
Time zone: CET (Central European Time)
As a leader in precision radiation therapy, Elekta is committed to ensuring every patient has access to the best cancer care possible. We openly collaborate with customers to advance sustainable, outcome-driven and cost-efficient solutions to meet evolving patient needs, improve lives and bring hope to everyone dealing with cancer. To us, it's personal, and our global team of 4,700 employees combine passion, science, and imagination to profoundly change cancer care. We don’t just build technology, we build hope. Elekta is headquartered in Stockholm, Sweden, with offices in more than 40 countries and listed on Nasdaq Stockholm. For more information, visit elekta.com or follow @Elekta on Twitter.